Valuation: Terumo Corporation

Market Cap 3,428B 21.51B 18.7B 17.41B 15.98B 30.18B 2,054B 30.65B 205B 80.52B 1,022B 80.79B 79.02B P/E 2027 *
20.4x
P/E 2028 * 18.2x
Enterprise Value 3,504B 21.99B 19.11B 17.79B 16.34B 30.85B 2,099B 31.33B 210B 82.31B 1,045B 82.58B 80.77B EV / Sales 2027 *
2.82x
EV / Sales 2028 * 2.61x
Free-Float
97.07%
Yield 2027 *
1.55%
Yield 2028 * 1.73%
1 day-3.79%
1 week+7.37%
1 month+4.03%
3 months+16.37%
6 months+15.19%
Current year+2.38%
1 week 2,177.5
Extreme 2177.5
2,459
1 month 2,133
Extreme 2133
2,459
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-3.79%+7.37%-9.25%-0.06% 21.51B
+0.09%+2.56%-16.24%-5.06% 183B
-0.37%+2.62%-5.37%-2.70% 109B
-0.29%+0.47%+8.83%+66.58% 60.57B
+3.50%+0.47%+28.65%+49.27% 51.8B
+0.10%+5.92%-7.09%-40.56% 45.64B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+3.32%-33.00% 31.49B
+0.40%+3.89%+42.51%-7.36% 24B
-1.22%+6.69%+0.84%+1.26% 22.26B
Average +1.08%+5.11%+5.13%+3.15% 58.27B
Weighted average by Cap. +0.75%+3.63%-1.67%+4.23%

Financials

2027 *2028 *
Net sales 1,242B 7.79B 6.77B 6.31B 5.79B 10.93B 744B 11.1B 74.32B 29.17B 370B 29.27B 28.62B 1,321B 8.29B 7.2B 6.71B 6.16B 11.63B 791B 11.81B 79.04B 31.02B 394B 31.12B 30.44B
Net income 168B 1.06B 919M 855M 785M 1.48B 101B 1.51B 10.08B 3.96B 50.22B 3.97B 3.88B 188B 1.18B 1.02B 953M 875M 1.65B 112B 1.68B 11.23B 4.41B 55.98B 4.42B 4.33B
Net Debt 75.98B 477M 414M 386M 354M 669M 45.52B 679M 4.55B 1.78B 22.66B 1.79B 1.75B 16.78B 105M 91.54M 85.21M 78.23M 148M 10.05B 150M 1B 394M 5B 395M 387M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
31/07/26 ¥2,324.00 -3.79% 5,158,600
30/07/26 ¥2,415.50 +1.39% 4,730,200
29/07/26 ¥2,382.50 +4.08% 6,546,900
28/07/26 ¥2,289.00 +1.78% 5,281,100
27/07/26 ¥2,249.00 +3.90% 4,788,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,324.00JPY
Average target price
3,023.08JPY
Spread / Average Target
+30.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock